Live tape
Top 8, mentions 7d14,338NVDA4,854 mentions▲ +0.04GOOGL2,061 mentions▲ +0.04SPY1,736 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,106 mentions▲ +0.05TSLA954 mentions▲ +0.04SNDK861 mentions▲ +0.05

Equity · Healthcare

IMMX

NASDAQ

Immix Biopharma (IMMX)

12.12 USD −4.68% vs prior close Sep 11, 2026
Immix Biopharma, Inc. price graph
22 sessions
16 10 12 Aug 11 Sep

The line runs 11.38 USD on 12 August through 12.12 USD on 11 September, on a scale from 10 to 16. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
867.1M USD
EPS, diluted, year to Dec 2025
−0.89 USD
52-week range
2 USD – 15 USD
Avg volume
102.2K

as of Sep 11, 2026

Have Immix Biopharma (IMMX) insiders bought or sold shares recently?

IMMX's newest Form 4 filing is dated 22 May 2026: none in the last 90 days.

Form 4

Have Immix Biopharma (IMMX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
10 Dec 2025Morris Gabriel SCFOBuy7705K USD
10 Dec 2025Rachman Ilya MCEO and ChairmanBuy7465K USD
Bought2 open-market purchases1,516$10K
9 other filings: grants, exercises, tax withholding and transfers, not trades
Have Immix Biopharma (IMMX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
22 May 2026Ng CareyDirectorAward6,250
22 May 2026Adams Helen C.DirectorAward6,250
22 May 2026Marquet MagdaDirectorAward6,250
22 May 2026CHANG NANCY TDirectorAward6,250
22 May 2026Chudnovsky YekaterinaDirectorAward6,250
22 May 2026BUCHAN JANEDirectorAward6,250
22 May 2026Hsu JasonDirectorAward6,250
08 Dec 2025Morris Gabriel SCFOIn-the-money exercise312,000125K USD
21 Nov 2025CHANG NANCY TAward39,643

Which funds hold Immix Biopharma (IMMX)?

6 of the 45 institutional funds we track reported a Immix Biopharma position for the quarter ended 30 Jun 2026 — a combined 50.7M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Immix Biopharma (IMMX)?
FundPositionSharesValueShares q/q
Millennium ManagementHeld (±25%)2,066,42621.3M USD+18.1%
Marshall WaceHeld (±25%)1,794,90818.5M USD+9.3%
Citadel AdvisorsAdded506,1575.2M USD+973.0%
Balyasny Asset ManagementNew position417,2274.3M USD
D. E. Shaw & Co.New position93,106960K USD
Two Sigma InvestmentsNew position40,181414K USD

What has been filed or recorded for Immix Biopharma (IMMX)?

The filings we hold for Immix Biopharma, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Immix Biopharma (IMMX)?
And
13 Oct 2026Fails to deliverShares failed to deliver3,198 shares30K USD notional · 0.004% of shares out
28 Sep 2026Fails to deliverShares failed to deliver6,166 shares68K USD notional · 0.009% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.18 USD
30 Jun 2026FinancialsTotal assets239.1M USDat period end
30 Jun 2026FinancialsTotal equity228.9M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.18 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −0.89 USD
31 Dec 2025FinancialsNet income−29.4M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.89 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.24 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.22 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.15 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −0.76 USD
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.24 USD

What do people ask about Immix Biopharma (IMMX)?

From live data
What did Immix Biopharma shares close at?12.12

Immix Biopharma closed at 12.12 USD on 11 Sep 2026, down 4.68% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Immix Biopharma’s market cap?867.1M

Immix Biopharma is worth 867.1M USD by market value as of 11 Sep 2026, which is the share price times the shares on issue from its SEC filings.

Have Immix Biopharma insiders bought or sold shares recently?

No Immix Biopharma insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 22 May 2026 (SEC Form 4). See Insiders

Which funds own Immix Biopharma?6 of 45

6 of the 45 funds we track reported a Immix Biopharma position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Marshall Wace and Citadel Advisors. See Funds

When did Immix Biopharma last report earnings?−0.18

Immix Biopharma last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.18 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings